Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epinosine B Forte in Symptomatic Diabetic Polyneuropathy
NCT07296354Phase 4Not yet recruiting
- Sponsor
- EIPICO
- Start
- Jan 2026
- Primary completion
- Feb 2028
01
Overview
A Phase 4 trial of Epinosine B Forte in diabetic polyneuropathy (DPN), sponsored by EIPICO. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
Epinosine B Forte
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on NCT07296354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07296354.